CLC bio and VIB Agree on an Academic Regional Site License
GHENT, Belgium & AARHUS, Denmark, Feb 09, 2012 (BUSINESS WIRE) -- Today, CLC bio and VIB, a life sciences research institute in Flanders, Belgium, announced the signing of an academic regional site license agreement for CLC bio's sequence analysis software CLC DNA Workbench. The software will be used across academic institutions in the Flanders region in Belgium, including Universiteit Gent, Katholieke Universiteit Leuven, University of Antwerp, and the Vrije Universiteit Brussel.
Herwig Van Marck, Manager of BITS, the facility that manages a portfolio of up-to-date bioinformatics software for scientists at VIB, states, "Bioinformatics is central to almost all areas of life sciences research today, so our researchers need access to the best and most innovative tools. When CLC bio added multisite gateway cloning to their suite, it was a straightforward decision to select this package for sequence data analysis."
Director of Communications at CLC bio, Lasse Gorlitz, continues, "With the whole life science field moving rapidly towards adopting DNA sequence analysis for a wide range of purposes, this is an important investment in biomolecular research for both the Flanders region and all of Belgium. VIB selecting to provide their researchers and students with access to cutting-edge and user-friendly bioinformatics tools, emphasizes VIB's commitment to spearheading life science research!"
VIB is a life sciences research institute in Belgium with more than 1200 scientists from over 60 countries, working in close partnership with Universiteit Gent, Katholieke Universiteit Leuven, University of Antwerp, and the Vrije Universiteit Brussel.
CLC bio is the world's leading bioinformatics solution provider and the only one who provides both desktop and server software seamlessly integrated and optimized for best performance. CLC bio maintains a strong scientific focus by initializing and participating in various research projects around the world, including multiple projects funded by US and EU grants.
About CLC bio
SOURCE: Clc bio